DHS COVID-19 PROVIDER RESOURCES // OMAP
Medical Assistance Bulletin 01-20-05, 08-20-09, 09-20-04,
28-20-01, 31-20-04, 33-20-02: Addition of Coronavirus Laboratory Test Codes
to the MA Program Fee Schedule
Effective: Feb. 4, 2020; Issued: May 1, 2020
Important Reminder: All providers must revalidate the Medical Assistance (MA) enrollment of each service location every five years. Providers should log into PROMISe™ to check the revalidation dates of each service location and submit revalidation applications at least 60 days prior to the revalidation dates. Enrollment (revalidation) applications may be found at https://www.dhs.pa.gov/providers/Providers/Pages/PROMISeEnrollment.aspx.
Purpose
The purpose of this bulletin is to notify providers that the Department of Human
Services (Department) is adding procedure codes for Coronavirus (COVID-19) laboratory tests
to the Medical Assistance (MA) Program Fee Schedule effective with dates of service on and
after February 4, 2020
Scope
This bulletin applies to physicians, certified registered nurse practitioners (CRNPs),
certified nurse midwives (CNMs), acute care general hospitals (hospitals), outpatient
laboratories and clinics that are enrolled in the Medical Assistance (MA) Program and render
services to MA beneficiaries in the fee-for-service delivery system and the managed care
delivery system. Physicians, CRNPs, CNMs, hospitals, outpatient laboratories and clinics that
render services to MA beneficiaries in the managed care delivery system should address any
billing, prior authorization or payment related questions to the appropriate managed care
organization (MCO).
Background
The Centers for Medicare & Medicaid Services (CMS) recently advised all Medicaid
agencies to take action to ensure clinical laboratories are prepared to test for Coronavirus.
Specifically, CMS and the American Medical Association (AMA) developed new Healthcare Common Procedure Coding System (HCPCS) and Current Procedure Terminology (CPT)
codes to allow providers, with the applicable CLIA certification, to bill and track COVID-19 virus
tests.
CMS announced the addition of two HCPCS codes intended for use to test and track
services related to COVID-19. In response to the CMS announcements to the COVID-19
public health emergency, the Department added the laboratory test codes to the MA Program
Fee Schedule, effective with dates of services on and after February 4, 2020 as follows:
- HCPCS code U0001, defined as “CDC 2019 - novel Coronavirus (2019-nCoV) realtime RT-PRC diagnostic panel,” is to be used specifically by Centers for Disease
Control and Prevention (CDC) laboratories to test patients for SARS-CoV-2.
- HCPCS code U0002, defined as “2019-nCoV Coronavirus, SARS-CoV-2/2019-nCov
(COVID-19), any technique, multiple types or subtypes (includes all targets), nonCDC” is to be used specifically for by laboratories to test non-CDC laboratory tests
for SARS-CoV-2/2019-nCoV (COVID-19).
The AMA announced the establishment of (3) new CPT codes to efficiently report and
track testing services related to COVID-19.
The department added the following laboratory test code to the MA Program Fee
Schedule, effective with dates of services on and after March 13, 2020.
- CPT code 87635, defined as “Infectious agent detection by nucleic acid (DNA or
RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(Coronavirus disease [COVID-19]), amplified probe technique.”
The department added the laboratory test codes to the MA Program Fee Schedule,
effective with dates of services on and after April 10, 2020 as follows:
- CPT code 86328, defined as “Immunoassay for infectious agent antibody(ies),
qualitative or semiquantitative, single step method (e.g., reagent strip); severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID19]).”
- CPT code 86769, defined as “Antibody; severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]).”
On April 14, 2020, CMS announced the creation of two new HCPCS Level II codes for
laboratory tests that use high-throughput technologies to detect SARS-CoV-2, the virus that
causes COVID-19. The Department added the laboratory test codes to the MA Program Fee
Schedule, effective with dates of service on and after April 14, 2020, as follows:
- HCPCS code U0003, defined as “Infectious agent detection by nucleic acid (DNA or
RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(Coronavirus disease [COVID-19]), amplified probe technique, making use of high
throughput technologies as described by CMS-2020-01-R”.
- HCPCS code U0004, defined as “2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV
(COVID-19), any technique, multiple types or subtypes (includes all targets), nonCDC, making use of high throughput technologies as described by CMS-2020-01
R”.
On April 24,2020, CMS announced that effective March 20, 2020, Medicare will permit
the use of HCPCS code U0002 QW and CPT code 87635 QW for claims submitted by facilities
with a valid, current Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver.
The department updated the MA Program Fee Schedule to allow the use of the QW
modifier for HCPCS code U0002 and CPT code 87635, effective with dates of services on and
after March 20, 2020.
The CDC noted that it will continue to review medical information related to the COVID19 virus. Providers are encouraged to monitor the CDC website for updated information and
clinical guidance on the COVID-19 virus by accessing the website at https://www.cdc.gov/COVID-19/2019-ncov/index.html.
Discussion
Consistent with the Administration’s commitment to ensuring the health and safety of all
Commonwealth citizens, the Department added the Coronavirus laboratory testing procedure
codes to the MA Program Fee Schedule as follows:
Procedure
Code
| Procedure Code
Description
| Provider
Type/
Specialty
| Place
of
Service
| MA
Fee
| Limits
| Prior
Authorization
Required
|
U0001
| CDC 2019 Novel
Coronavirus
Real Time RTPRC Diagnostic
Test Panel
| 01/183
01/016
01/017
28/280
| 22
23
23
81
| $28.07
| 1 to 3
per
day
| No
|
U0002
| 2019-nCoV
Coronavirus,
SARS-CoV2/2019-nCov
(COVID-19), any
technique,
multiple types or
subtypes (includes all targets) non-CDC
| 01/183
01/183
01/016
01/016
01/017
01/017
08/082
08/082
| 22
22/QW
23
23/QW
23
23/QW
49
49/QW
| $28.07
| 1 to 3
per
day
| No
|
U0003
| 2019
-nCoV
Coronavirus,
SARS-CoV
-
2/2019
-nCoV
(COVID-19), any
technique,
multiple types or
subtypes
(includes all
targets), non
-
CDC
| 01/183
28/280
| 22
81
| $80
| 1 per
day
| No
|
U0004
| 2019
-nCoV
Coronavirus,
SARS-CoV
-
2/2019
-nCoV
(COVID-19), any
technique,
multiple types or subtypes
(includes all
targets), non
-
CDC
| 01/183
28/280
| 22
81
| $80
| 1 per
day
| No
|
87635
| Infectious agent
detection by
nucleic acid
(DNA or RNA);
severe acute
respiratory
syndrome
coronavirus 2
(SARS-CoV
-2)
(Coronavirus
disease [COVID
19]), amplified
probe technique
| 01/183
01/183
01/016
01/016
01/017
01/017
08/082
08/082
09/All
09/All
28/280
28/280
31/All
31/All 33/335
33/335
| 22
22/QW
23
23/QW
23
23/QW
49
49/QW
11
11/QW
81
81/QW
11
11/QW 11
11/QW
| $35.49
| 1 per
day
| No
|
86328
| Immunoassay
for infectious
agent
antibody(ies),
qualitative or
semiquantitative,
single step
method (e.g.,
reagent strip);
severe acute
respiratory
syndrome
coronavirus 2
(SARS-CoV-2)
(Coronavirus
disease [COVID19])
| 01/183
28/280
| 22
81
| $5.58
| 1 per
day
| No
|
86769
| Antibody; severe
acute respiratory
syndrome
coronavirus 2
(SARS-CoV-2)
(Coronavirus
disease [COVID19])
| 01/183
28/280
| 22
81
| $11.16
| 1 per
day
| No
|
Procedure
Providers are to bill and the Department will pay for COVID-19 laboratory testing as
described above.
Information on MA Program coverage related to COVID-19, to include an FAQ
document, can be found on the Department of Human Services website here.
The Pennsylvania Department of Health has a dedicated page for COVID-19 that
provides regular updates. Click here for the most up to date information regarding COVID-19.
Comments and Questions